glaziovianin-a and Neoplasms

glaziovianin-a has been researched along with Neoplasms* in 3 studies

Other Studies

3 other study(ies) available for glaziovianin-a and Neoplasms

ArticleYear
Design, synthesis, and biological evaluation of the analogues of glaziovianin A, a potent antitumor isoflavone.
    Bioorganic & medicinal chemistry, 2012, Oct-01, Volume: 20, Issue:19

    Various analogues of glaziovianin A, an antitumor isoflavone, were synthesized, and their biological activities were evaluated. O(7)-modified glaziovianin A showed strong cytotoxicity against HeLa S(3) cells. Compared to glaziovianin A, the O(7)-benzyl and O(7)-propargyl analogues were more cytotoxic against HeLa S(3) cells and more potent M-phase inhibitors. Furthermore, O(7)-modified molecular probes of glaziovianin A were synthesized for biological studies.

    Topics: Antineoplastic Agents; Cell Survival; Drug Design; HeLa Cells; Humans; Isoflavones; M Phase Cell Cycle Checkpoints; Neoplasms; Structure-Activity Relationship

2012
Structure-activity relationship study of glaziovianin A against cell cycle progression and spindle formation of HeLa S3 cells.
    Bioorganic & medicinal chemistry letters, 2010, Sep-15, Volume: 20, Issue:18

    Various derivatives of glaziovianin A, an antitumor isoflavone, were synthesized, and the cytotoxicity of each against HeLa S3 cells was investigated. Compared to glaziovianin A, the O7-allyl derivative was found to be more cytotoxic against HeLa S3 cells and a more potent M-phase inhibitor.

    Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Fabaceae; HeLa Cells; Humans; Isoflavones; Neoplasms; Structure-Activity Relationship

2010
Glaziovianin A, a new isoflavone, from the leaves of Ateleia glazioviana and its cytotoxic activity against human cancer cells.
    Bioorganic & medicinal chemistry letters, 2007, Jun-01, Volume: 17, Issue:11

    A new isoflavone, named glaziovianin A (1), was isolated from the leaves of Ateleia glazioviana (Legminosae) by means of a cytotoxicity-guided fractionation procedure against HL-60 leukemia cells. The chemical structure of 1 was determined by analysis of its extensive spectroscopic data. Glaziovianin A (1) displayed differential cytotoxicities in the Japanese Foundation for Cancer Research 39 cell line panel assay. The pattern of the differential cytotoxicities of 1 was found to correlate to that shown by TZT-1027, suggesting that 1 inhibited tubulin polymerization as an action mechanism. Although 1 had little influence on microtubule networks in interphase cells, 1-treated cells showed abnormal structures with unaligned chromosomes.

    Topics: Antineoplastic Agents; Cell Division; Cell Line, Tumor; Fabaceae; HL-60 Cells; Humans; Isoflavones; Neoplasms; Oligopeptides; Plant Leaves; Tubulin

2007